Caxton Associates (New York)’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,070	Closed	-$521K	–	337
2020 Q2	$521K	Buy	2,070 +1,371	+196%	+$345K	0.05%	116
2020 Q1	$110K	Buy	+699	New	+$110K	0.02%	377